These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23928182)

  • 1. An overview of the diagnostic tools.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
    Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
    Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.
    Brown P
    Vox Sang; 2005 Aug; 89(2):63-70. PubMed ID: 16101685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
    Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
    Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future uncertain for reliable vCJD screening tests.
    Bonn D
    Lancet; 2000 Jul; 356(9225):228. PubMed ID: 10963208
    [No Abstract]   [Full Text] [Related]  

  • 8. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.
    Edgeworth JA; Farmer M; Sicilia A; Tavares P; Beck J; Campbell T; Lowe J; Mead S; Rudge P; Collinge J; Jackson GS
    Lancet; 2011 Feb; 377(9764):487-93. PubMed ID: 21295339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
    Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
    Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for the development of pre-mortem laboratory diagnostic tests for Creutzfeldt-Jakob disease.
    Dabaghian RH; Mortimer PP; Clewley JP
    Rev Med Virol; 2004; 14(6):345-61. PubMed ID: 15495196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid screening and confirmatory methods for biochemical diagnosis of human prion disease.
    Ugnon-Café S; Dorey A; Bilheude JM; Streichenberger N; Viennet G; Meyronet D; Maues de Paula A; Perret-Liaudet A; Quadrio I
    J Virol Methods; 2011 Aug; 175(2):216-23. PubMed ID: 21619894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
    Pan T; Sethi J; Nelsen C; Rudolph A; Cervenakova L; Brown P; Orser CS
    Transfusion; 2007 Aug; 47(8):1418-25. PubMed ID: 17655586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underestimation of the expression of cellular prion protein on human red blood cells.
    Panigaj M; Brouckova A; Glierova H; Dvorakova E; Simak J; Vostal JG; Holada K
    Transfusion; 2011 May; 51(5):1012-21. PubMed ID: 21058954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-prion antibodies for prophylaxis following prion exposure in mice.
    Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
    Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and strain properties of CJD prions: complexity versus simplicity.
    Haïk S; Brandel JP
    J Neurochem; 2011 Oct; 119(2):251-61. PubMed ID: 21790605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.